Uptake of a Novel, Disposable CD4 Point-of-Care CD4 Test in Developing Countries

Scaling up access to contemporary diagnostics for tuberculosis (GeneXpert) with a focus on HIV-associated TB, drug-resistant TB and early TB case detection

Innovation in paediatric market access (IPMA)

FIND: Sustainable Global and National Quality Control for Malaria Rapid Diagnostic Tests (RDT)

Open polyvalent platforms for sustainable and quality access to Viral Load in resource limited settings

Preventing patent barriers

E-market place for the procurement of public health commodities

Creating a Private Sector Market for Quality Assured RDTs in Malaria-Endemic Countries

(PQ Meds II) WHO Prequalification of Medicines and Diagnostics: Increased access to appropriate, quality-assured diagnostics, medical devices and medicines for prevention, initiation and treatment of HIV/AIDS, TB and Malaria

UNITAID/PSI HIV Self-Testing Africa (STAR)

Catalytic Long Lasting Insecticidal Nets (LLIN) initiative

Support to Round 6 of the Global Fund to fight AIDS, TB and Malaria

Introduction of point-of-care Early Infant Diagnosis in decentralized settings: creating a market for affordable, effective, and equitable HIV testing of exposed infants

Market entry of an improved solid protease inhibitor-based first-line ARV combination therapy for infants and young children with HIV/AIDS

UNICEF: PMTCT Nutrition

Supply of  Paediatric (Peds) TB medicines

UNICEF: Acceleration of Prevention of Mother-to-Child Transmission (PMTCT) and Scale up of Linkages to Paediatric HIV Care and Treatment for 2007-2009

UNICEF: PMTCT Expansion (PMTCT II)

Multi-Drug Resistant (MDR)-TB Scale-up and Acceleration of Access Project

MDR TB Acceleration of Access Initiative: Strategic Rotating Stockpile

Malaria Prevention-Long Lasting Insecticide Treated Nets (LLINs)

Cost containment, price reductions and increased access to first-line anti-TB drugs

Operational Studies to Validate and Accelerate Uptake of Point-of-Care CD4 Counters

Facilitate and secure the availability of ARV treatments and their proper administration to people living with HIV/AIDS in five African Countries

Additional Support to the Coordinated Procurement Planning (CPP) Initiative

Scaling up access to contemporary TB diagnostics (Buy-down)

Accelerating access to Innovative POC HIV diagnostics

Medicines Patent Pool Foundation II

HIV/HCV Drug Affordability Project

UNICEF, WHO: UNITAID support to Liberia & Burundi for supply of ACTs for 2007

Safer, More Robust and Less Expensive Antiretroviral First-Line Therapy (ADVANCE Trial)

Accelerating access and integration of innovative point of care (POC) HIV technologies in national diagnostics programs Phase 2b

Accelerating access to innovative point of care (POC) HIV diagnostics Phase 2a

Malaria market intelligence to evaluate global investments and define sustainable strategic options that ensure access to high quality commodities

Providing Access to Early Infant Diagnosis & Viral Load Monitoring by SAMBA – A POC Nucleic Acid Detection System

The Medicines Patent Pool Foundation

Improving Severe Malaria Outcomes by strengthening the market for severe malaria treatment (injectable and intrarectal artesunate) and analyzing market potential for pre-referral treatment

A Global Network to Improve Access and Quality of HIV Monitoring Technologies

Implementation of CD4 and VL testing in decentralized resource-limited settings

A randomised trial to compare dolutegravir + pharmaco-enhanced darunavir versus recommended standard of care antiretroviral regimens in patients with HIV infection who have failed recommended first-line therapy

Unlocking the Hepatitis C diagnostic and treatment market

WHO HTM Enabler Grant

WHO TB Enabler

RTS,S/AS01 Pilot Implementation Programme

Rectal Artesunate - RAS

Enabling access to a robust and well-tolerated new-generation first-line antiretroviral treatment in low-income countries

Achieving Catalytic Expansion of SMC Services in the Sahel to Save Lives

WHO Malaria Enabler Grant

WHO HTM Enabler HIV-HCV sub-grant Self-Testing component

Paediatric TB Center of Excellence

Access to Treatment for People Living with HIV in Middle Income Countries

TB SPEED: Strengthening paediatric TB services for enhanced early detection

Catalyzing Paediatric TB Innovations

Market Intervention to accelerate uptake of new vector control tools

Preparedness for the Rollout of Effective HIV Prevention among Key Affected Populations in Brazil, Peru and Mexico

Expand New Drugs for TB (endTB)

Accelerating Patient Access to Optimal Antiretrovials

Supply Side grant

Autotest, libre d'accéder à la connaissance de son Statut VIH

Ensuring access to the HCV treatment revolution for HCV/HIV co-infected patients in low and middle income countries

Increasing Market and Public health outcomes through scaling up Affordable Access models of short Course preventive therapy for TB

Dolutegravir in Pregnant HIV Mothers and Neonates

Transforming IPT for Optimal Pregnancy (TIPTOP)

Integrating PrEP into Comprehensive Services for Adolescent Girls and Young Women

Accelerating demand for HIVST among young people in Western and Southern Africa

(PQ Dx II) WHO Prequalification of Medicines and Diagnostics: Increased access to appropriate, quality-assured diagnostics, medical devices and medicines for the prevention, initiation and treatment of HIV/AIDS, TB and Malaria

Open polyvalent platforms for sustainable access to quality and affordable viral load testing in resource-limited settings – Phase 2

Unitaid support to WHO prequalification of medicines and in vitro diagnostics, and to the WHO collaborative procedure for registration

Broad One Health Endectocide-based Malaria Intervention in Africa (BOHEMIA)

ADVANCING SPATIAL REPELLENTS FOR VECTOR-BORNE DISEASE CONTROL

Expanding the use of TRIPS flexibilities to promote affordable access to medicines

Health for All: Increasing access to HIV, TB and hepatitis C medicines through effective use of TRIPS flexibilities

Assured Artemisinin Supply System (A2S2)

Use of TRIPS flexibilities to increase affordability of treatment for HIV and HIV/HCV co-infection in MICs